1. Home
  2. DPC vs AMRX Comparison

DPC vs AMRX Comparison

Compare DPC & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DPC Holdings PLC Ordinary Shares

DPC

DPC Holdings PLC Ordinary Shares

N/A

Current Price

$44.19

Market Cap

6.4B

Sector

N/A

ML Signal

N/A

Logo Amneal Pharmaceuticals Inc.

AMRX

Amneal Pharmaceuticals Inc.

N/A

Current Price

$17.51

Market Cap

6.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DPC
AMRX
Founded
N/A
2002
Country
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.4B
6.2B
IPO Year
2026
2018

Fundamental Metrics

Financial Performance
Metric
DPC
AMRX
Price
$44.19
$17.51
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$15.60
AVG Volume (30 Days)
757.6K
1.7M
Earning Date
N/A
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
157.89
EPS
N/A
0.37
Revenue
N/A
N/A
Revenue This Year
N/A
$4.48
Revenue Next Year
N/A
$7.13
P/E Ratio
N/A
$48.68
Revenue Growth
N/A
N/A
52 Week Low
$42.50
$9.32
52 Week High
$57.25
$19.26

Technical Indicators

Market Signals
Indicator
DPC
AMRX
Relative Strength Index (RSI) 43.74 47.96
Support Level $43.27 $16.61
Resistance Level $50.85 $18.13
Average True Range (ATR) 3.16 0.58
MACD -0.54 -0.07
Stochastic Oscillator 20.32 46.73

Price Performance

Historical Comparison
DPC
AMRX

About DPC DPC Holdings PLC Ordinary Shares

DPC Holdings PLC is a manufacturer of complex precision cast components for aerospace engines and industrial gas turbines. It produces metal components and specialized products for aerospace and industrial applications and operates manufacturing facilities across multiple locations globally.

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Share on Social Networks: